Laurie Toich, Assistant Editor

Three weeks of radiation post-mastectomy observed to be safe and effective for breast cancer patients.

Daily reports of antibiotic prescriptions lessened unnecessary treatment among infants in the neonatal intensive care unit.

Prescription for Life offers free educational training to high school students about prescription opioid misuse.

Top news of the day from across the healthcare landscape.

Gains in healthcare access were made among lower-income Americans living in states that expanded Medicaid under the Affordable Care Act.

Activation of glutamine-releasing neurons in the brain stem resulted in lower food consumption.

Boehringer Ingelheim and Eli Lilly partner with ACC to highlight the role of cardiologists in heart health among diabetes patients.

New cases of HIV in Swaizland down 50% between 2011 and 2016.

Rising breast cancer rates in Japan highlights the need for clinical trials that include this population.

Targeting the microenvironment of lung cancer tumors with immunotherapies show promise.

Top news of the day from across the healthcare landscape.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, explores how combining medical and pharmacy benefits could result in a better understanding of a certain drug's value.

Biosimilar to filgrastim (Neupogen) favored over branded drug in Express Scripts 2018 formulary.

Nivolumab (Opdivo) approved to treat microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.

Nivolumab approved for form of metastatic colorectal cancer that typically does not respond to chemotherapy.

Adalimumab (Humira) biosimilar being tested as an interchangeable drug for plaque psoriasis.

New research calls into question long-accepted guidelines for antibiotic use.

Nearly 1 million cancer deaths in China were the result of exposure to modifiable risk factors.

New clinical trial tests experimental drugs in pediatric and adolescent patients.

Providing gift cards observed to increase viral suppression among HIV-positive patients.

Top news of the day from across the healthcare landscape.

PCMA report suggests that DIR fees will save $308.2 billion between 2017 and 2026, while critics say the report is misleading.

Direct and indirect remuneration fees continue to generate controversy across the pharmacy landscape.

Discovery may lead to new immunotherapies for aggressive breast cancer.

Dicovery could lead to more effective treatments for influenza, rhinovirus, and HIV.

Aripiprazole (Abilify Maintena) found to delay manic episodes in adults with bipolar 1 disorder.

Top news of the day from across the healthcare landscape.

Top articles of the week from The American Journal of Pharmacy Benefits.

FDA plans multifaceted attack to reduce the burden of opioids on Americans.

Medicaid insurance not observed to create a barrier to receiving healthcare.